APA (7th ed.) Citation

E, H., H, A., O, B., C, W., S, B., A, G., . . . D, P. (2025). Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling. Journal of translational medicine, 23(1), 1048. https://doi.org/10.1186/s12967-025-07203-w

Chicago Style (17th ed.) Citation

E, Hunter, et al. "Development and Validation of Blood-based Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Using EpiSwitch® 3-dimensional Genomic Regulatory Immuno-genetic Profiling." Journal of Translational Medicine 23, no. 1 (2025): 1048. https://doi.org/10.1186/s12967-025-07203-w.

MLA (9th ed.) Citation

E, Hunter, et al. "Development and Validation of Blood-based Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Using EpiSwitch® 3-dimensional Genomic Regulatory Immuno-genetic Profiling." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1048, https://doi.org/10.1186/s12967-025-07203-w.